Court Ruling Finds that ERISA Preempts State PBM Law COURT REJECTS BID TO PREEMPT ERISA…In a unanimous decision, the U.S. Court of Appeals for the Tenth Circuit in PCMA v. Mulready court sustained PCMA’s challenge to four provisions in
Pharmacy benefit companies are strong proponents of a highly functioning biosimilar market. Bringing more biosimilars to market, over time, will allow PBMs to more effectively leverage competition to reduce drug costs for health plan sponsors and patients. As biosimilar competition
Blumenthal-Cornyn Legislation Would Encourage More Generic and Biosimilar Competition in the Prescription Drug Market to Help Lower Costs for Patients (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today following the reintroduction of the “Affordable
Click here to read PCMA’s letter to the Administration’s COVID-19 Task Force. As the Pharmaceutical Care Management Association (PCMA) closely monitors the COVID-19 outbreak, our industry’s priority is that Americans have ready access to the medications that they need in
Fact: Employers are under no obligation to hire pharmacy benefit companies, but a vast majority of employers work with pharmacy benefit companies. Recent findings from the PricewaterhouseCoopers (PwC) 2021 “Health and Well-being Touchstone Survey” of 368 companies explains why employers,
The federal government spends a lot of money on prescription drugs. Medicare Part D, the program to help seniors pay for their prescription drugs, provides benefits to 45 million people and its budget for the upcoming fiscal year will exceed $90
©2024 PCMA. All Rights Reserved.
